Results

Total Results: 1,795 records

Showing results for "cost".

61. Disposition of Comments_Comparative Effectiveness Review No. 265_Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-disposition-comments.pdf
    August 29, 2023 - Cost analysis and perhaps an introductory figure to compare treatment methods would be useful. … We agree that costs matter. … We agree that costs matter. … No cost analysis is done - on policy it is key to understand that SBRT bills at a higher rate so use … Formal evaluation of treatments costs or cost-effectiveness was not within the scope of this review

62. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Diffusion and cost: Lumacaftor/ivacaftor reportedly costs about $20,000 for a 4-week supply ($260,000 … Orkambi pricing info. [internet]. Santa Monica (CA): GoodRx, Inc. … Xolair pricing information. [internet]. Santa Monica (CA): GoodRx, Inc. … Nintedanib (Ofev) pricing info. [database online]. Santa Monica (CA): GoodRx, Inc. … Pirfenidone (esbriet) pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

63. Long-Term Care for Older Adults Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_disposition-comments.pdf
    November 07, 2012 - It does not analyze societal costs. See the discussion above on costs. … Are acute care costs limited to Medicaid or do they include Medicare costs? … cost studies include indirect or family caregiving costs. … We revised the cost section and toned down the findings. … Reviewer #9 Discussion Discussion-53: See the comments above on the cost analysis.

64. S77 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
    October 01, 2007 - Key Words: drug costs, insurance coverage, Part D, veterans (Med Care 2007;45: S77–S80) Medicare Part … Because changing these parameters alters the out-of-pocket cost under Medicare Part D, we tested cost … Medical Care • Volume 45, Number 10 Suppl 2, October 2007 Veterans Drug Costs and Medicare Part D © … Patient strategies to cope with high prescription medication costs: who is cutting back on necessities … Problems due to medication costs among VA and non-VA patients with chronic illnesses.

65. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The wholesale cost was reported as $2,055 per month for 30 tablets, or about $25,000 annually, a cost … Experts thought that tofacitinib might have more favorable pricing than injectable biologic therapies … , which could lower costs for patients. … Tofacitinib might have more favorable pricing than injectable biologic therapies (which is yet to be … the cost of the biologics.

66. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
    November 01, 2016 - No cost, coverage, coding, or payment information is available yet, but elagolix is expected to cost … Food and Drug Administration (FDA).4 Cost implications: No cost information is available yet, but elagolix … is expected to cost more than available peptide GnRH receptor agonists, some of which are available … overall health care costs if patients drive demand for this drug. … Leuprolide (Lupron) pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

67. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
    November 01, 2016 - No cost, coverage, coding, or payment information is available yet, but elagolix is expected to cost … Food and Drug Administration (FDA).4 Cost implications: No cost information is available yet, but elagolix … is expected to cost more than available peptide GnRH receptor agonists, some of which are available … overall health care costs if patients drive demand for this drug. … Leuprolide (Lupron) pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

68. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - EES issued a self-funded cost study stating that the anticipated per-procedure costs of using the Sedasys … Variables affecting adherence (e.g., medication affordability, access, side effects) caused some skepticism … Cost: The cost of using the Sedasys system has not been released by the manufacturer, but it could … acknowledged that digital medicines do not address several other adherence variables (e.g., medication affordability … cost impact with postdischarge clinics, experts suggested, which could offset the initial cost of

69. Hypertension-Drugs-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
    January 25, 2011 - Further, it examines costs of antihypertensive drugs. … Cost of Antihypertensive Drugs Among Those With Hypertension Total drug cost and total out-of-pocket … The total reimburse- ment cost of ACEIs, BBs, and CCBs decreased from 2007 to 2009, while the costs … Similar trends were observed for total antihyper- tensive drug costs. … The annual total drug cost was calculated as the sum of the ingredient cost, dispensing fee, sales

70. Infectious Disease Including HIV/AIDS #09 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
    December 01, 2015 - TB drug susceptibility testing costs about $102.119 According to one cost analysis of incorporating … Xpert MTB/RIF testing would add minimal costs or would eventually be cost-saving, experts thought. … Sovaldi pricing information. [internet]. Santa Monica (CA): GoodRx, Inc. … Copegus pricing information. [internet]. Santa Monica (CA): GoodRx, Inc. … Harvoni pricing info. [internet]. Santa Monica (CA): GoodRx, Inc.

71. Considering the Range of Decision-Relevant Effects (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
    June 01, 2012 - to society (opportunity costs) Cost as an Outcome Segal JB. … Cost as an Outcome Additional cost outcomes might also be considered if appropriate to the systematic … Costs: Cost of tests to patients and payers Opportunity costs Diagnostic Test Example: Computerized … Costs associated with access to the testing location (e.g., travel costs) Cost of treating comorbidities … Cost of treating the adverse effects of testing Cost to manufacture the test All of the above None of

72. Considering the Range of Decision-Relevant Effects (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
    June 01, 2012 - to society (opportunity costs) Cost as an Outcome Segal JB. … Cost as an Outcome Additional cost outcomes might also be considered if appropriate to the systematic … Costs: Cost of tests to patients and payers Opportunity costs Diagnostic Test Example: Computerized … Costs associated with access to the testing location (e.g., travel costs) Cost of treating comorbidities … Cost of treating the adverse effects of testing Cost to manufacture the test All of the above None of

73. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
    January 01, 2009 - managers working with physicians to promote appropriate utilization of services and to facilitate cost … Outcomes(s): Health services utilization and cost. … meet an individual's health needs through communication and available resources to promote quality cost … In some cases, nurse case management has been shown to reduce costs, hospital length of stay, and readmissions

74. Horizon Scanning Status Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/horizon-scan
    May 15, 2012 - October 01, 2015 Research Report Report of a Pilot Project: Rapid Cost … Analyses of Selected Potential High-Impact Intervention Reports October 01, 2015 Research

75. Closing the Quality Gap Series: The Effects of Bundled Payment Strategies on Health Care Spending and Quality of Care | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bundled-payments-quality-effects/research-protocol
    June 23, 2011 - a health care provider payment method in which the payment is related to the predetermined expected costs … are lower than a threshold level set below expected costs. … of bundled payments, providers may select low-risk patients and avoid those with higher risks (and costs … Provider cost/resource use to deliver episodes (e.g., cost per implanted device, average length of inpatient … Administrative cost of payment method.

76. Outcome Definition and Measurement in Observational Comparative Effectiveness Research
    effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
    January 01, 2013 - Monetary costs Direct versus indirect costs Health resource utilization Often used as efficient and easily … Cost-effectiveness is a relative concept, and its analysis compares the costs and benefits of treatments … Monetary Costs Studies most often examine direct costs (monetary costs of medical treatments themselves … ) but may also include measures of indirect costs (costs of disability or loss of livelihood, both actual … Utility and Preference-Based Measures Patient-reported outcomes and cost analyses intersect around the

77. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - If not, costs would increase to an extent. … Saxenda pricing info. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2015 Jun 01]. … Belviq (lorcaserin) pricing info. [internet]. Santa Monica (CA): GoodRx, Inc. … Contrave pricing information. [internet]. Santa Monica (CA): GoodRx, Inc. … Xenical pricing info. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2014 Oct 07].

78. Key Question Alternative Payment Models (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alternative-payment-models_0.pdf
    August 01, 2024 - Medicaid and the Children’s Health Insurance Program (CHIP).1 There is increasing attention to the cost … Based on historical trends, healthcare treatment costs are expected to increase significantly in the … as a reimbursement strategy incentivizing health systems and providers to implement high-quality, cost-efficient … measures to improve care delivery, encourage coordination across the healthcare ecosystem, manage costs … Outcomes Total cost of care, hospitalizations, re-hospitalizations, ED visits; mental health metrics

79. Topic 0494 Tacrolimus Monitoring and Treatment Renal Transplantation NSD FINAL (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0583-131115.pdf
    March 13, 2013 - standard dose tacrolimus Outcome(s): better organ survival rate, fewer rejections, less nephrotoxicity, cost … b. fewer rejections, c. less nephrotoxicity, d. cost … monitoring (C0) produce: a. better organ survival rate, b. fewer rejections, c. less nephrotoxicity, d. cost … producing a. better organ survival rate, b. fewer rejection episodes, c. less nephrotoxicity, d. cost … immunoassay analysis for: 1) organ survival, 2) acute and long-term rejections, 3) nephrotoxicity, 4) costs

80. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - No cost information is available at this time. … They thought that tofacitinib might have more favorable pricing (which has yet to be determined) than … articlekey=9521 4 health disparities by adding to costs. … Tofacitinib might have more favorable pricing than injectable biologic therapies (which has yet to … be set at about two-thirds the cost of biologics.